SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (4188)7/10/1998 12:17:00 PM
From: Anthony Wong  Respond to of 9523
 
More analyst ratings: ING Baring Furman, Bear Stearns, Deutsche Bank

Pfizer Inc. Maintained 'Hold' at ING Baring Furman

Bloomberg News
July 10, 1998, 9:20 a.m. ET

Princeton, New Jersey, July 10 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was maintained ''hold'' by analyst James E. Flynn at ING Baring Furman Selz
LLC.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652

More News: PFE

Pfizer Inc. Reiterated 'Attractive' at Bear Stearns

Bloomberg News
July 10, 1998, 8:51 a.m. ET

Princeton, New Jersey, July 10 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was reiterated ''attractive'' by analyst Joseph Riccardo at Bear, Stearns & Co.
The 12-month target price is $125.00 per share.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652

Pfizer Inc. Maintained 'Accumulate' at Deutsche Bank

Bloomberg News
July 10, 1998, 8:41 a.m. ET

Princeton, New Jersey, July 10 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was maintained ''accumulate'' by analyst Mariola B. Haggar at Deutsche Bank
Securities. The 12-month target price is $135.00 per share.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652